Search Results - "pharmacometrics"

Optimized sampling to estimate vancomycin drug exposure: Comparison of pharmacometric and equation‐based approaches in a simulation‐estimation study by David W. Uster, Sebastian G. Wicha

Connect to this object online.

Analysis of Longitudinal‐Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models by Tong Lu, Yujie Yang, Jin Y. Jin, Matts Kågedal

Connect to this object online.

Predicting Cost‐Effectiveness of Generic vs. Brand Dabigatran Using Pharmacometric Estimates Among Patients with Atrial Fibrillation in the United States by Ching‐Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown

Connect to this object online.

Optimization of trial duration to predict long‐term HbA1c change with therapy: A pharmacometrics simulation‐based evaluation by Hanna Kunina, Alex Al‐Mashat, Jenny Y. Chien, Parag Garhyan, Maria C. Kjellsson

Connect to this object online.

Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients by Christiane Dings, Peter Meiser, Frank Holzer, Michael Flegel, Dominik Selzer, Eszter Nagy, Ralph Mösges, Jens Peter Klussmann, Thorsten Lehr

Connect to this object online.

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d'Ivoire by Veshni Pillay-Fuentes Lorente, Jacinta N. Nwogu-Attah, Britta Steffens, Dominic Bräm, Viviane Sprecher, Daniela Hofmann, Michael Buettcher, Goonaseelan Pillai, Samer Mouksassi, Jean Coulibaly, Marc Pfister, Jennifer Keiser

Connect to this object online.

Pharmacometric analyses of alectinib to facilitate approval of the optimal dose for the first‐line treatment of anaplastic lymphoma kinase-positive non‐small cell lung cancer by Joy C. Hsu, Felix Jaminion, Elena Guerini, Bogdana Balas, Walter Bordogna, Peter N. Morcos, Nicolas Frey

Connect to this object online.

A Combined Pharmacometrics Analysis of Biomarker Distribution Under Treatment With Standard- or Low-Dose Rivaroxaban in Real-World Chinese Patients With Nonvalvular Atrial Fibrillation by Nan Zhao, Nan Zhao, Zhiyan Liu, Qiufen Xie, Zhe Wang, Zhe Wang, Zhongyi Sun, Qian Xiang, Yimin Cui, Yimin Cui, Yimin Cui

Connect to this object online.

Quantitative assessment of the relevance of organic-anion-transporting-polypeptide 1B1 and 2B1 polymorphisms in fexofenadine pharmacokinetic variants via pharmacometrics by Ji-Hun Jang, Seung-Hyun Jeong, Yong-Bok Lee

Connect to this object online.

The Emerging Discipline of Quantitative Systems Pharmacology by Tarek A. Leil

Subjects: “…pharmacometrics…”
DOAB: download the publication
DOAB: description of the publication

Torsemide Pharmacometrics in Healthy Adult Populations Including CYP2C9 Genetic Polymorphisms and Various Patient Groups through Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling by Seung-Hyun Jeong, Ji-Hun Jang, Yong-Bok Lee

Connect to this object online.

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice by Roganović Maša, Homšek Ana, Jovanović Marija, Topić-Vučenović Valentina, Ćulafić Milica, Miljković Branislava, Vučićević Katarina

Connect to this object online.

An introduction to causal inference for pharmacometricians by James A. Rogers, Hugo Maas, Alejandro Pérez Pitarch

Connect to this object online.

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies by Peter Bloomingdale, Tatiana Karelina, Murat Cirit, Sarah F. Muldoon, Justin Baker, William J. McCarty, Hugo Geerts, Sreeraj Macha

Connect to this object online.

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development by A R Maharaj, A N Edginton

Connect to this object online.

Importance of Stability Analysis When Using Nonlinear Semimechanistic Models to Describe Drug‐Induced Hematotoxicity by Chiara Fornari, Carmen Pin, James W.T. Yates, Jerome T. Mettetal, Teresa A. Collins

Connect to this object online.

The Use of Biotechnological Drugs in Pediatrics on the Example of Monoclonal Antibodies: Clinical Pharmacology View by Alexey S. Kolbin, Liudmila I. Yemelyanova

Connect to this object online.

Step‐by‐step comparison of ordinary differential equation and agent‐based approaches to pharmacokinetic‐pharmacodynamic models by Van Thuy Truong, Paul G. Baverel, Grant D. Lythe, Paolo Vicini, James W. T. Yates, Vincent F. S. Dubois

Connect to this object online.

Linking the Population Pharmacokinetics of Tenofovir and Its Metabolites With Its Cellular Uptake and Metabolism by K Madrasi, R N Burns, C W Hendrix, M J Fossler, A Chaturvedula

Connect to this object online.

Systematic Analysis of New Drug Indications by Drug‐Gene‐Disease Coherent Subnetworks by L Wang, Y Wang, Q Hu, S Li

Connect to this object online.